Acorah Software Products - Accounts Production 16.1.200 false true 31 December 2022 1 January 2022 false 1 January 2023 31 March 2024 31 March 2024 10515711 Mr Daniel Gore Mrs Sri Gore iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10515711 2022-12-31 10515711 2024-03-31 10515711 2023-01-01 2024-03-31 10515711 frs-core:CurrentFinancialInstruments 2024-03-31 10515711 frs-core:ComputerEquipment 2024-03-31 10515711 frs-core:ComputerEquipment 2023-01-01 2024-03-31 10515711 frs-core:ComputerEquipment 2022-12-31 10515711 frs-core:MotorVehicles 2024-03-31 10515711 frs-core:MotorVehicles 2023-01-01 2024-03-31 10515711 frs-core:MotorVehicles 2022-12-31 10515711 frs-core:ShareCapital 2024-03-31 10515711 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 10515711 frs-bus:PrivateLimitedCompanyLtd 2023-01-01 2024-03-31 10515711 frs-bus:FilletedAccounts 2023-01-01 2024-03-31 10515711 frs-bus:SmallEntities 2023-01-01 2024-03-31 10515711 frs-bus:AuditExempt-NoAccountantsReport 2023-01-01 2024-03-31 10515711 frs-bus:SmallCompaniesRegimeForAccounts 2023-01-01 2024-03-31 10515711 frs-bus:Director1 2023-01-01 2024-03-31 10515711 frs-bus:Director1 2022-12-31 10515711 frs-bus:Director1 2024-03-31 10515711 frs-bus:Director2 2023-01-01 2024-03-31 10515711 frs-countries:EnglandWales 2023-01-01 2024-03-31 10515711 2021-12-31 10515711 2022-12-31 10515711 2022-01-01 2022-12-31 10515711 frs-core:CurrentFinancialInstruments 2022-12-31 10515711 frs-core:ShareCapital 2022-12-31 10515711 frs-core:RetainedEarningsAccumulatedLosses 2022-12-31
Registered number: 10515711
Eye Consultants Ltd
Unaudited Financial Statements
For the Period 1 January 2023 to 31 March 2024
Sharpe Medical Accounting Ltd
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 10515711
31 March 2024 31 December 2022
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 40,978 472
40,978 472
CURRENT ASSETS
Debtors 5 128,516 214,135
Cash at bank and in hand 197,517 189,855
326,033 403,990
Creditors: Amounts Falling Due Within One Year 6 (219,008 ) (119,670 )
NET CURRENT ASSETS (LIABILITIES) 107,025 284,320
TOTAL ASSETS LESS CURRENT LIABILITIES 148,003 284,792
NET ASSETS 148,003 284,792
CAPITAL AND RESERVES
Called up share capital 7 100 100
Profit and Loss Account 147,903 284,692
SHAREHOLDERS' FUNDS 148,003 284,792
Page 1
Page 2
For the period ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Daniel Gore
Director
Mrs Sri Gore
Director
18/11/2024
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Eye Consultants Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 10515711 . The registered office is Sharpe Medical Accounting Ltd, Normanby Gateway, Lysaghts Way, Scunthorpe, DN15 9YG.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is recognised when a company gains entitlement to receive income from a third party.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Motor Vehicles 25.00%WDV
Computer Equipment 25% straight line
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Page 3
Page 4
3. Average Number of Employees
Average number of employees, including directors, during the period was: 2 (2022: 3)
2 3
4. Tangible Assets
Motor Vehicles Computer Equipment Total
£ £ £
Cost
As at 1 January 2023 - 1,168 1,168
Additions 37,811 4,527 42,338
As at 31 March 2024 37,811 5,695 43,506
Depreciation
As at 1 January 2023 - 696 696
Provided during the period 788 1,044 1,832
As at 31 March 2024 788 1,740 2,528
Net Book Value
As at 31 March 2024 37,023 3,955 40,978
As at 1 January 2023 - 472 472
5. Debtors
31 March 2024 31 December 2022
£ £
Due within one year
Trade debtors 51,195 48,364
Prepayments and accrued income 390 13,927
Other debtors 1,420 1,420
Other taxes and social security 380 -
Directors' loan accounts 75,131 150,424
128,516 214,135
Page 4
Page 5
6. Creditors: Amounts Falling Due Within One Year
31 March 2024 31 December 2022
£ £
Corporation tax 212,812 112,459
Other taxes and social security - 1
Other creditors 2,382 -
Accruals and deferred income 3,814 7,210
219,008 119,670
7. Share Capital
31 March 2024 31 December 2022
£ £
Allotted, Called up and fully paid 100 100
8. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 January 2023 Amounts advanced Amounts repaid Amounts written off As at 31 March 2024
£ £ £ £ £
Mr Daniel Gore 150,424 75,130 150,424 - 75,130
The above loan is unsecured and repayable on demand. Interest has been charged on this loan at 2.5%.
Page 5